Asset Details
Do you wish to reserve the book?
Incidence of Nd:YAG laser capsulotomy following cataract surgery: a population-based nation-wide study – FreYAG1 study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Incidence of Nd:YAG laser capsulotomy following cataract surgery: a population-based nation-wide study – FreYAG1 study
Do you wish to request the book?
Incidence of Nd:YAG laser capsulotomy following cataract surgery: a population-based nation-wide study – FreYAG1 study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Incidence of Nd:YAG laser capsulotomy following cataract surgery: a population-based nation-wide study – FreYAG1 study
2023
Overview
Rationale
Nd:YAG (neodymium:yttrium-aluminum-garnet) capsulotomy (
Nd:YAG-caps
) is the gold standard for the treatment of PCO (Posterior Capsule Opacification). There is a lack of real-world data about
Nd:YAG-caps
use.
Purpose
This study’s objectives were to estimate
Nd:YAG-caps
incidence in France, to describe the patient characteristics, and to analyze the time between surgeries and capsulotomies. Setting: The study was based on data extracted from the EGB database, a 1/97th sample representative of the French population. Design: observational, retrospective, cohort study using national claims data.
Methods
French adult patients who underwent
Nd:YAG-caps
between 2014 and 2017 were selected. Main outcomes were the number of patients and procedures performed and the risk factors associated with early
Nd:YAG-caps
. Results: During the study period,
Nd:YAG-caps
were performed in 8,425 patients accounting for 10,774 procedures. The extrapolation to the French population led to estimate that 253.10
3
patients had
Nd:YAG-caps
, representing 312.10
3
procedures in 2017. The mean age at
Nd:YAG-caps
was 75.1 (± 10.2) years. About 36% of patients presented at least one ocular comorbidity.
Nd:YAG-caps
was performed within 2 years after surgery in 33.0% of patients and within one year in 9.8% of patients. Patients with
Nd:YAG-caps
within the first year (OR CI95 0.721 [0.673–0.772]) or in the first two years (OR CI95 0.721 [0.673–0.772]) were younger than patients with later
Nd:YAG-caps
and had a more frequent history of treated ocular diseases (OR 1.516 and 1.178, respectively).
Conclusions
This study brought new real-world and large-scale data regarding
Nd:YAG-caps
use and gave an updated insight into the patients’ characteristics.
Publisher
BioMed Central,Springer Nature B.V,BMC
Subject
/ Age
/ Aged
/ Aluminum
/ Capsule Opacification - epidemiology
/ Capsule Opacification - etiology
/ Capsule Opacification - surgery
/ Cataract
/ Diabetes
/ Disease
/ DRGs
/ Gender
/ Glaucoma
/ Humans
/ Laser Therapy - adverse effects
/ Lasers
/ Lasers, Solid-State - therapeutic use
/ Lens Capsule, Crystalline - surgery
/ Lens Implantation, Intraocular
/ Medicine
/ Nd:YAG
/ Patients
/ Postoperative Complications - etiology
/ Santé publique et épidémiologie
/ Surgery
/ Yttrium
